Song J., Luo J., Ma Z., Sun Q., Wu C., Li X. Quality and Authenticity Control of Functional Red Yeast Rice-A Review (англ.) // Molecules : journal. — 2019. — Vol. 24, no. 10. — doi:10.3390/molecules24101944. — PMID3113594.
Monascus secondary metabolites: production and biological activity (англ.) // Journal Ind. Microbiol. Biotechnol.. — 2013. — Vol. 40, no. 2. — P. 169—181. — doi:10.1007/s10295-012-1216-8. — PMID23179468.
The Original Source of Modern Research on Chinese Medicinal Materials: Bencao Texts (англ.) // J Altern Complement Integr Med : journal. — 2017. — Vol. 3. — P. 045. — doi:10.24966/ACIM-7562/100045.
Heber D., Yip I., Ashley J. M., Elashoff D. A., Elashoff R. M., Go V. L. Cholesterol-lowering effects of a proprietary Chinese red-yeast-rice dietary supplement (англ.) // Am J Clin Nutr[англ.] : journal. — 1999. — Vol. 69, no. 2. — P. 231—236. — doi:10.1093/ajcn/69.2.231. — PMID9989685.
Statins in hypercholesterolaemia: a dose-specific meta-analysis of lipid changes in randomised, double blind trials (англ.) // BMC Fam Pract : journal. — 2003. — Vol. 4. — P. 18. — doi:10.1186/1471-2296-4-18. — PMID14969594.
Marked Variability of Monacolin Levels in Commercial Red Yeast Rice Products: Buyer Beware! (англ.) // JAMA : journal. — 2010. — Vol. 170, no. 19. — P. 1722—1727. — doi:10.1001/archinternmed.2010.382. — PMID20975018.
Identification and chemical profiling of monacolins in red yeast rice using high-performance liquid chromatography with photodiode array detector and mass spectrometry (англ.) // J Pharm Biomed Anal : journal. — 2004. — Vol. 35, no. 5. — P. 1101—1112. — doi:10.1016/j.jpba.2004.04.004. — PMID15336357.
Traditional Chinese lipid-lowering agent red yeast rice results in significant LDL reduction but safety is uncertain – a systematic review and meta-analysis (англ.) // Atherosclerosis : journal. — 2015. — Vol. 240, no. 2. — P. 415—423. — doi:10.1016/j.atherosclerosis.2015.04.004. — PMID25897793.
Adverse reactions to dietary supplements containing red yeast rice: assessment of cases from the Italian surveillance system (англ.) // Br J Clin Pharmacol[англ.] : journal. — 2017. — Vol. 83, no. 4. — P. 894—908. — doi:10.1111/bcp.13171. — PMID28093797.
Song J., Luo J., Ma Z., Sun Q., Wu C., Li X. Quality and Authenticity Control of Functional Red Yeast Rice-A Review (англ.) // Molecules : journal. — 2019. — Vol. 24, no. 10. — doi:10.3390/molecules24101944. — PMID3113594.
Monascus secondary metabolites: production and biological activity (англ.) // Journal Ind. Microbiol. Biotechnol.. — 2013. — Vol. 40, no. 2. — P. 169—181. — doi:10.1007/s10295-012-1216-8. — PMID23179468.
Heber D., Yip I., Ashley J. M., Elashoff D. A., Elashoff R. M., Go V. L. Cholesterol-lowering effects of a proprietary Chinese red-yeast-rice dietary supplement (англ.) // Am J Clin Nutr[англ.] : journal. — 1999. — Vol. 69, no. 2. — P. 231—236. — doi:10.1093/ajcn/69.2.231. — PMID9989685.
Statins in hypercholesterolaemia: a dose-specific meta-analysis of lipid changes in randomised, double blind trials (англ.) // BMC Fam Pract : journal. — 2003. — Vol. 4. — P. 18. — doi:10.1186/1471-2296-4-18. — PMID14969594.
Marked Variability of Monacolin Levels in Commercial Red Yeast Rice Products: Buyer Beware! (англ.) // JAMA : journal. — 2010. — Vol. 170, no. 19. — P. 1722—1727. — doi:10.1001/archinternmed.2010.382. — PMID20975018.
Identification and chemical profiling of monacolins in red yeast rice using high-performance liquid chromatography with photodiode array detector and mass spectrometry (англ.) // J Pharm Biomed Anal : journal. — 2004. — Vol. 35, no. 5. — P. 1101—1112. — doi:10.1016/j.jpba.2004.04.004. — PMID15336357.
Traditional Chinese lipid-lowering agent red yeast rice results in significant LDL reduction but safety is uncertain – a systematic review and meta-analysis (англ.) // Atherosclerosis : journal. — 2015. — Vol. 240, no. 2. — P. 415—423. — doi:10.1016/j.atherosclerosis.2015.04.004. — PMID25897793.
Lu Z. L. [China coronary secondary prevention study (CCSPS)] (Chinese) // Zhonghua Xin Xue Guan Bing Za Zhi. — 2005. — Т. 33, № 2. — С. 109—115. — PMID15924803.
Statin alternatives or just placebo: an objective review of omega-3, red yeast rice and garlic in cardiovascular therapeutics (англ.) // Chin. Med. J.[англ.] : journal. — 2008. — Vol. 121, no. 16. — P. 1588—1594. — PMID18982874.
[Red yeast-rice-induced muscular injuries: Analysis of French pharmacovigilance database and literature review] (фр.) // Thérapie. — 2016. — doi:10.2515/therapie/2015053. — PMID28277227.
Adverse reactions to dietary supplements containing red yeast rice: assessment of cases from the Italian surveillance system (англ.) // Br J Clin Pharmacol[англ.] : journal. — 2017. — Vol. 83, no. 4. — P. 894—908. — doi:10.1111/bcp.13171. — PMID28093797.
nccih.nih.gov
Red Yeast Rice (неопр.). NIH: National Center for Complementary and Integrative Health. Дата обращения: 28 декабря 2018. Архивировано 28 декабря 2018 года.
Red Yeast Rice (неопр.). NIH: National Center for Complementary and Integrative Health. Дата обращения: 28 декабря 2018. Архивировано 28 декабря 2018 года.
Heber D., Yip I., Ashley J. M., Elashoff D. A., Elashoff R. M., Go V. L. Cholesterol-lowering effects of a proprietary Chinese red-yeast-rice dietary supplement (англ.) // Am J Clin Nutr[англ.] : journal. — 1999. — Vol. 69, no. 2. — P. 231—236. — doi:10.1093/ajcn/69.2.231. — PMID9989685.
Statin alternatives or just placebo: an objective review of omega-3, red yeast rice and garlic in cardiovascular therapeutics (англ.) // Chin. Med. J.[англ.] : journal. — 2008. — Vol. 121, no. 16. — P. 1588—1594. — PMID18982874.
Adverse reactions to dietary supplements containing red yeast rice: assessment of cases from the Italian surveillance system (англ.) // Br J Clin Pharmacol[англ.] : journal. — 2017. — Vol. 83, no. 4. — P. 894—908. — doi:10.1111/bcp.13171. — PMID28093797.
